Back
Clearwater Paper 10K Form
Buy
54
CLW
Clearwater Paper
Last Price:
$32.67
Seasonality Move:
-4.8%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-04-29 | 10Q | CLW/Clearwater Paper Quarterly |
2023-10-30 | 10Q | CLW/Clearwater Paper Quarterly |
2023-08-01 | 10Q | CLW/Clearwater Paper Quarterly |
2023-05-02 | 10Q | CLW/Clearwater Paper Quarterly |
2022-10-31 | 10Q | CLW/Clearwater Paper Quarterly |
2022-08-02 | 10Q | CLW/Clearwater Paper Quarterly |
Receive CLW News And Ratings
See the #1 stock for the next 7 days that we like better than CLW
CLW Financial Statistics
Sales & Book Value
Annual Sales: | $2.1B |
---|---|
Cash Flow: | $-30.8M |
Price / Cash Flow: | 9.56 |
Annual Sales: | $40.06 |
Price / Book: | 0.76 |
Profitability
EPS (TTM): | 0.83000 |
---|---|
Net Income (TTM): | $14.8M |
Gross Margin: | $330.8M |
Return on Equity: | 2.23% |
Return on Assets: | 0.74% |
Clearwater Paper Earnings Forecast
Key Clearwater Paper Financial Ratios
-
The Gross Profit Margin over the past 18 years for CLW is 15.88%.
-
The Selling, General & Administrative Expenses for CLW have been equal to 7.16% of Gross Profit Margin.
-
The Research & Development expenses have been 0.00% of Revenue.
-
The Interest Expense is 28.88% of Operating Income.
-
The Net Earning history of CLW is 5.17% of Total Revenues.
-
Per Share Earnings over the last 17 years have been positive in 9 years.
Clearwater Paper Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NYSE |
---|---|
Industry: | Paper & Forest Products |
Sector: | Materials |
Current Symbol: | CLW |
CUSIP: | 18538R |
Website: | clearwaterpaper.com |
Debt
Debt-to-Equity Ratio: | 1.73 |
---|---|
Current Ratio: | 1.78 |
Quick Ratio: | 0.51 |
Price-to-Earnings
Trailing P/E Ratio: | 4.81 |
---|---|
Forward P/E Ratio: | 25.03 |
CLW Technical Analysis vs Fundamental Analysis
Buy
54
Clearwater Paper (CLW)
is a Buy
Is Clearwater Paper a Buy or a Sell?
-
Clearwater Paper stock is rated a BuyThe current Clearwater Paper [CLW] share price is $30.29. The Score for CLW is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.